Funes Sandrine, Hedrick Joseph A, Yang Shijun, Shan LiXin, Bayne Marvin, Monsma Frederick J, Gustafson Eric L
Human Genome Research, Schering-Plough Research Institute, Kenilworth, NJ 07033, USA.
Peptides. 2002 Sep;23(9):1607-15. doi: 10.1016/s0196-9781(02)00097-9.
Neuromedin U (NmU) is a neuropeptide involved in various physiological functions such as feeding behavior, muscle contractile activity, and regulation of intestinal ion transport. Recently, two human G protein-coupled receptors have been identified as NmU-specific receptors, NmU-R1 and NmU-R2, which share 55% amino acid identity. It is unclear however, which of the two receptors mediates responses to NmU observed in rodent models. Attempts to define the pharmacological profile of the two receptors are confounded by overlapping expression of the two receptors and a lack of subtype-selective compounds. In order to establish a basis to further our understanding of the function of these receptors, we cloned and characterized the mouse homologues of the two human NmU receptors. Mouse NmU-R1 and mouse NmU-R2 are 79 and 81% identical to their respective human homologues. Expression of NmU-R1 was mainly observed in testis, gastrointestinal (GI) tract, and immune system, while NmU-R2 was primarily expressed in brain tissues. Each mouse receptor was independently expressed in HEK293 cells and demonstrated a dose-dependent calcium flux in response to NmU-8, NmU-23 and NmU-25. In an attempt to identify a synthetic NmU peptide that would exhibit selectivity at one of the two receptors, we examined the functional activity of eight alanine-substituted NmU-8 peptides. These experiments demonstrated that alanine substitution at positions 5 and 7 affects the functional activity of the peptide at both receptors. The arginine residue at position 7 is required for NmU-8 activity at either receptor while alanine substitution at position 5 selectively affects the potency and the efficacy at mNmU-R1. These experiments validate the use of rodent models to characterize NmU function relative to humans and suggest that substitution at Arginine-5 of NmU-8 may provide a receptor selective peptide.
神经介素U(NmU)是一种神经肽,参与多种生理功能,如摄食行为、肌肉收缩活动以及肠道离子转运的调节。最近,两种人类G蛋白偶联受体已被鉴定为NmU特异性受体,即NmU-R1和NmU-R2,它们的氨基酸同一性为55%。然而,尚不清楚这两种受体中哪一种介导在啮齿动物模型中观察到的对NmU的反应。由于这两种受体的表达重叠以及缺乏亚型选择性化合物,确定这两种受体的药理学特征的尝试受到了干扰。为了建立进一步了解这些受体功能的基础,我们克隆并鉴定了两种人类NmU受体的小鼠同源物。小鼠NmU-R1和小鼠NmU-R2与其各自的人类同源物分别有79%和81%的同一性。NmU-R1的表达主要在睾丸、胃肠道(GI)和免疫系统中观察到,而NmU-R2主要在脑组织中表达。每种小鼠受体在HEK293细胞中独立表达,并对NmU-8、NmU-23和NmU-25表现出剂量依赖性钙流。为了鉴定一种在两种受体之一上具有选择性的合成NmU肽,我们检测了八种丙氨酸取代的NmU-8肽的功能活性。这些实验表明,第5和第7位的丙氨酸取代会影响该肽在两种受体上的功能活性。第7位的精氨酸残基是NmU-8在任一受体上发挥活性所必需的,而第5位的丙氨酸取代选择性地影响mNmU-R1的效力和效能。这些实验验证了使用啮齿动物模型来表征相对于人类的NmU功能,并表明NmU-8的精氨酸-5位取代可能提供一种受体选择性肽。